No Data
No Data
Windtree Therapeutics Files to Sell 40M Shares of Common Stock for Holders
Windtree Announces Special Late-Breaking Clinical Science Abstract Presentation on Istaroxime at the Technology and Heart Failure Therapeutics Conference
Trending Stocks Today | Mynaric Surges 63.6% Pre-Market
Why Upstart Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket
Windtree Therapeutics Expands Oncology IP With New Japanese Patent For APKCi Inhibitor
Express News | Windtree Announces Japanese Patent Titled "Inhibitors of Atypical Protein Kinase C (APKCi) and Their Use in Treating Hedgehog Pathway-dependent Cancers." Expiring In 2040